Priority Date: 01.04.13 (KR 20130035292)

Combination therapy using anti-c-met antibody and sorafenib

  • Application ID: EP14162863
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 201 - 500 employees
Company dna grunecker kinkeldey stockmair and schwanhausser
operating since 1924
Headquarter in Munich and 2 offices
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 191 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 01.04.2013 - Priority Date (KR 20130035292)
  • 08.10.2014 - Publication A2 (EP2786764)
  • 05.11.2014 - Publication A3 (EP2786764)
  • 08.03.2017 - Publication B1 (EP2786764)

IPC Classification